This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the U.S. Department of Health and Human Services, to Aalto Bio Reagents Limited, a for-profit limited liability company based in Ireland. The award, with a firm fixed price of $3,935.00, is for the purchase of 5 units of AMBIS 1699473 AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120 ANTIBODY at a unit price of $787.00 per unit. The contract does not have a set-aside designation and...
This is a firm-fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Aalto Bio Reagents Limited, a for-profit limited liability company, for the provision of reagents. The contract has a ceiling value of $9,000.00 and a period of performance ending on February 28, 2015. The contract was awarded on February 13, 2015 and was not set aside for any specific business category.
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. Department of Health and Human Services (HHS), to Aalto Bio Reagents Limited, a for-profit limited liability company. The award, valued at $9,204.00, is for the purchase of 13 vials of 2 mg each of "AFFINITY PURIFIED SHEEP ANTI-HIV-1-GP120" at $728.00 per vial. The contract has a firm fixed price and an ultimate completion date of March 31, 2014. The...
<p>The federal contract award HHSN272201401008P was granted to Hycult Biotech Inc. by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services. The contract is for the delivery of antibodies, valued at $3,346.75 on a firm fixed price basis. The contract was awarded on September 3, 2014 with an ultimate completion date of October 3, 2014. The contract does not have a set-aside designation.</p>
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $10,580.00 firm fixed-price purchase order to Lofstrand Labs LTD, a for-profit limited liability company, for antibody production and purification services. The contract does not have a set-aside designation and has an ultimate completion date of May 26, 2017. Lofstrand Labs LTD is the prime contractor, and no subcontractors are mentioned. The award is not associated with a larger contract vehicle...
<p>The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $45,900.00 firm fixed price purchase order to Ehime University, a non-profit organization, for antibodies production services. This contract, with a completion date of February 1, 2014, was not set aside for any specific business type. No additional context about NIAID's programs was provided.</p>
This is a $575,850.00 fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the In Vitro Antimicrobial Assessments 2011-2018 indefinite-delivery, indefinite-quantity (IDIQ) contract. The contract was awarded to Access To Advanced Health Institute (AAHI), a nonprofit biotech research institute located in Seattle, Washington. The contract is for unspecified "OTHER FUNCTIONS" and does not have a set-aside designation. As a prime...
<p>This federal contract award, valued at $13,390.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract was awarded to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business, for the provision of proteins and antibodies. The contract is a firm fixed price purchase order with an ultimate completion date of August 5, 2016. There is no set-aside designation for this award.</p>
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to BioLegend, Inc., a for-profit manufacturer of biomedical reagents, antibodies, proteins, and other products to support life science research and drug discovery. The $26,552.50 contract is for the procurement of a TOTALSEQ-A antibody conjugate panel and two additional anti-human antibodies for...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $16,345.50 purchase order to Biointron Biological USA Inc. for antibody expression services. As a firm fixed price contract, Biointron will provide the requested antibody expression services to NIH/NIAID at Metuchen, New Jersey from September 19, 2023 through December 29, 2023. No subcontractors or set aside designations were indicated. NIAID conducts and...